Related Experiment Video
Updated: Apr 7, 2026
03:33
Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
1.2K
Current Helicobacter pylori treatment in 2014
Fatih Ermis1, Elif Senocak Tasci1
1Fatih Ermis, Department of Gastroenterology, Duzce University Faculty of Medicine, 81620 Duzce, Turkey.
World Journal of Methodology
|July 4, 2015
Summary
Helicobacter pylori eradication therapies are evolving due to rising antimicrobial resistance. Current recommendations favor quadruple therapies and individualized treatment plans, with adjuvant therapies showing promise.
Area of Science:
- Microbiology
- Gastroenterology
- Infectious Diseases
Background:
- Helicobacter pylori is a prevalent bacterium linked to various gastrointestinal diseases.
- Increasing antimicrobial resistance is reducing the effectiveness of standard empirical therapies.
- High clarithromycin resistance necessitates alternative treatment strategies.
Purpose of the Study:
- To review current Helicobacter pylori eradication regimens.
- To highlight challenges posed by antimicrobial resistance.
- To discuss alternative and adjuvant therapeutic approaches.
Main Methods:
- Review of current literature on H. pylori treatment guidelines.
- Analysis of different eradication strategies, including triple, quadruple, concomitant, sequential, and hybrid therapies.
- Evaluation of levofloxacin-based therapy and individualized treatment approaches.
- Assessment of adjuvant therapies such as probiotics, statins, and n-acetylcysteine.
Main Results:
- Standard triple therapy is less effective in regions with high clarithromycin resistance.
- Quadruple therapies are increasingly recommended globally.
- Debate exists regarding levofloxacin-based regimens due to quinolone resistance concerns.
- Culture-guided individualized therapies are advised when standard regimens fail.
- Adjuvant therapies may enhance eradication success.
Conclusions:
- Effective H. pylori eradication requires adapting treatment strategies to local resistance patterns.
- Quadruple and individualized therapies are crucial for overcoming antimicrobial resistance.
- Further research into novel therapeutic approaches and adjuvant treatments is warranted.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.2K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.2K
01:26Peptic Ulcer Disease IV: Management
663
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
663
01:27Peptic Ulcer
31
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
31
01:23Gastritis III: Clinical Manifestations and Management
1.7K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.7K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
820
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
820
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.3K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.3K